Search is Powered by Google
Cancer / Oncology News

People More Likely To Attend Cancer Screening Close To Christmas And Birthdays

Main Category: Cancer / Oncology
Also Included In: MRI / PET / Ultrasound;  Radiology / Nuclear Medicine
Article Date: 30 Dec 2008 - 0:00 PST

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article


Current Article Ratings:

Patient / Public:not yet rated

Health Professional:1 star

1 (1 votes)

Article Opinions: 0 posts

Cancer screening programmes could increase attendance by inviting people for screening close to birthdays or other annual milestones such as Christmas and the New Year, finds a study in the Christmas issue published on bmj.com.

Colorectal cancer (bowel cancer) is the third most common cancer in the UK and the second leading cause of cancer deaths in Europe and the US. But despite the promotion of screening programmes in many western countries, attendance is generally low. Previous studies have identified barriers to attendance including anxiety and lack of knowledge about the test's risks and benefits, but the influence of age as a motivating factor, and the timing of invitations on screening attendance has never been tested.

Professor Geir Hoff and Michael Bretthauer from The Cancer Registry of Norway, examined whether tailoring the timing of colorectal cancer screening invitations to annual milestones such as birthdays, Christmas and the New Year, can improve attendance.

They randomly recruited 20,780 men and women aged 50 - 64 years from the population registry in Norway, and randomly assigned a screening appointment to them. The attendance rates for each week and month of assigned appointments were compared to participants' week/month of birthday. The overall attendance was 12,960 out of 20,003 (64.7%).

The researchers found that attendance rates were significantly higher in December compared to the rest of the year (72.3% versus 64.2%), and for individuals receiving their letter of invitation in the week of their birthday or assigned to screening 1 - 2 weeks after their birthday (67.9% versus 64.5%).

Age, being female, screening method, and geographical area of living were also independent predictors of attendance.

The authors suggest that invitation to screening close to the date of individuals' birthdays and to the month of December may improve attendance at screening programmes as well as its effectiveness for the prevention and early detection of disease.

Although the reasons for this are unknown, they may relate to annual reminders of ageing triggered by annual milestones such as birthdays and Christmas and the New Year, conclude the authors.

"Research paper: The impact of appointments timed in proximity to annual milestones on compliance with screening: randomised controlled trial"
BMJ Online
Click here to view Abstract online

About BMJ (British Medical Journal)

The BMJ is published by BMJ Publishing Group Ltd, a wholly owned subsidiary of the British Medical Association. The editor of the BMJ is Fiona Godlee.

www.bmj.com




Personalized Homepage Weekly Newsletters Daily News Alerts
Opioid Induced Constipation ADHD Anxiety Asthma Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles All 'How To...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Swine Flu Image

Swine Flu Updates

- Latest Swine Flu News
- What is Swine Flu?
- Map Of H1N1 Outbreaks
- Swine Flu - Top 20 FAQ
- Daily Email News Alerts
Stick with Medical News Today for the latest news updates on swine flu.


These are the most read articles from this news category for the last 6 months:
Top Article Star
Understanding And Treating Triple-Negative Breast Cancer
07 Jan 2009
Triple-negative breast cancer is a subtype of breast cancer that is clinically negative for expression of estrogen and progesterone receptors (ER/PR) and HER2 protein. It is characterized by its unique molecular profile...


Monitoring and Adherence in CML image Monitoring and Adherence in CML

Imatinib, or Gleevec, is a targeted anti-cancer drug that can keep chronic myelogenous leukemia (CML) in check for most patients for many years. It is important for patients to take imatinib as prescribed by their doctor to fight the disease and to guard against resistance...

Treating HER2+ Breast Cancer image Treating HER2+ Breast Cancer

There are at least four different kinds of breast cancer and each is treated differently. For HER2+ breast cancer, a chemotherapy drug is typically the best option. Here's an overview of the drugs used to treat breast cancer...

View more videos...